Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute
Advertisement
Articles by Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute
Advertisement
Latest Updated Articles
Rapid Readouts: Phase 1/2 KRYSTAL-1 TrialNovember 18th 2020
Advertisement
Advertisement
Trending on OncLive
1
Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma
2
ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC
3
mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC
4
FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors
5